Grant Street Asset Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
RCM
Grant Street Asset Management's NVAX Position: Q2 2021 in Review
Grant Street Asset Management sold out of Novavax (NVAX) in Q2 2021, closing a stake of 90 shares — an estimated $16K sold.
Grant Street Asset Management first reported a position in NVAX in Q4 2020 and held it in 2 quarters. The position peaked at $16K in Q1 2021. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.
- Grant Street Asset Management reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
- Grant Street Asset Management sold 90 Novavax shares in Q2 2021, an estimated $16K.
- Grant Street Asset Management first reported a position in Novavax in Q4 2020 and held it in 2 quarters.
- Grant Street Asset Management's Novavax position peaked at $16K in Q1 2021.
- 407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.
Based on Grant Street Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.